Oculopharyngeal Muscular Dystrophy Clinical Trial
Official title:
Natural History Study of Oculopharyngeal Muscular Dystrophy
The objective of this study is to test a set of clinical outcome measures longitudinally in a cohort of OPMD patients to identify ones that show quantifiable change over time as the disease progresses. The investigators' goal is to delineate the natural history of OPMD.
OPMD patients will undergo a screening evaluation and testing to confirm the participants carry the OPMD mutation. Subjects fulfilling the inclusion/exclusion criteria will be enrolled and followed prospectively at regular intervals to determine the natural history of this disease. Measures of muscle function and swallowing will be made at baseline and at follow-up visits to measure natural clinical progression. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02877784 -
Screening in Oculopharyngeal Muscular Dystrophy
|
||
| Recruiting |
NCT06185673 -
A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT04009408 -
Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders
|
N/A | |
| Recruiting |
NCT03874910 -
Pathology Analysis of OPMD Patient Myotomies
|
||
| Withdrawn |
NCT04226924 -
Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose
|
Phase 2 | |
| Recruiting |
NCT02158156 -
Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy
|
N/A | |
| Completed |
NCT02015481 -
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
|
Phase 2 |